Accessibility & Affordability
Innovative treatments and cures are an integral part of our health care system and can help patients live longer, healthier lives. But vital medicines only work if patients have access. To ensure medical innovation continues to benefit patients, medicines must be both affordable and accessible.
LATEST ARTICLES
Providing Patients with Cost Information and Tools to Navigate Insurance Coverage
The biopharmaceutical industry is dedicated to finding lifesaving treatments but also making sure pa…
READ MORE
World Health Day: How Do We Afford the New Era of Medicine?
For World Health Day, the World Health Organization reminds us that “everyone, everywhere should be…
READ MORE
Patient Resources
America's Biopharmaceutical Companies are researching and developing thousands of new treatments and…
READ MORE
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and ins…
READ MORERELATED ARTICLES
Addressing Health Inequities in Communities of Color
America's biopharmaceutical companies recognize the need for evidence-based research and cross-secto…
READ MORE
World IP Day: How Intellectual Property Protections Spur Innovation
Every April 26, we celebrate World Intellectual Property Day as a way to remember the critical role…
READ MORE
Researcher Profile: Stephanie Bartner
Stephanie’s interest in becoming a research analyst for Sanofi was personal.
READ MORE
Fixing Medicare for America’s Seniors
Ensuring timely, affordable access to new medicines for seniors has never been more vital.
READ MORE
Changes to the Health Care System Should Prioritize Patient Affordability
A group of experts recently discussed the ways we can realign the U.S. health care system to improve…
READ MORE
Here's the Reason America Is an Innovation Powerhouse
American policies prioritize innovation and patient access.
READ MORE
3 Groundbreaking Innovations That Were First Approved in the United States
Breakthrough therapies are approved in America quickly, and this translates to hope for patients and…
READ MORE
Why Washington Shouldn't Copy the Flawed Pricing Policies of Other Countries
America is the world's leading source of innovation. Let's keep it that way.
READ MORE
Moving Toward a Value-Driven Health Care System
To advance a value-driven care system, we need better information, a focus on outcomes that matter t…
READ MORE
Researcher Profile: David Cobden
Learn about what America's biopharmaceutical companies are doing to ensure we can continue to afford…
READ MORE
Innovation is Fragile, But Worth Protecting
The Atlantic, in partnership with PhRMA's GOBOLDLY campaign, convened thought leaders to discuss the…
READ MORE
Achieving Innovation and Access Together
In today's new era of medicine, breakthrough treatments are revolutionizing how we fight disease, pr…
READ MORE
Tackling Overdose and Addiction with Novel Treatments
In a few weeks, on August 31, the world will recognize International Overdose Awareness Day, which t…
READ MORE
How the New Era of Medicine is Disrupting Health Care
We are on the cusp of a major, positive disruption in the U.S. health care system due in part to the…
READ MORE
Innovative Medicines Deserve an Innovative Payment System
Over the past several years, we've witnessed an unprecedented pace of innovation which has ushered i…
READ MORE
Technology and Health Care Working Together to Improve Patient Care
Pairing technology and medicine together has the potential to create revolutions in health care that…
READ MORE
Policy Solutions to Push Progress Forward
We are in a new era of medical discovery and have the potential to revolutionize the treatment of co…
READ MORE
Our Commitment
We are America's Biopharmaceutical Companies, driven to discover the next lifesaving breakthrough an…
READ MORE